Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

May 29, 2021

Primary Completion Date

December 2, 2021

Study Completion Date

December 2, 2021

Conditions
COVID-19 Respiratory InfectionFLUCold; InfluenzaBacterial PneumoniaCOVID-19 Pneumonia
Interventions
DIETARY_SUPPLEMENT

Kunamin®

Grape juice, seed, stem and rice extracts supplement containing KH good healthy cells (proteins)

DRUG

Favipiravir

Antiviral medication used to treat influenza

DRUG

Enoxaparin

Anticoagulant medication

DRUG

Lansoprazole

Treat stomach ulcers, a damaged esophagus, gastroesophageal reflux disease (GERD), and high levels of stomach acid.

DRUG

Paracetamol

Analgesic to treat minor aches and pains, and fever reducer.

DRUG

Ceftriaxone/ Clarithromycin

Inhibits the production of pneumolysin

DRUG

Methylprednisolone

Treat inflammation, severe allergies, flares of chronic illnesses

Trial Locations (1)

38080

Kayseri City Hospital, Kayseri

All Listed Sponsors
collaborator

Kayseri City Hospital

OTHER_GOV

lead

RAAS Nutritionals, LLC

INDUSTRY